Qiming-Backed AI Drug Discovery Startup Insilico Medicine Hits Unicorn Status With $110 Million Funding Round
Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...
Abu Dhabi’s MGX Hires From Apollo, Warburg Amid Trump’s AI Push
Abu Dhabi’s MGX, which is helping bankroll the $100 billion artificial intelligence venture touted by Donald Trump, is ...
The Pharma Letter13h
Fosun Pharma to sell hospital group stake for $124 million
Chinese pharmaceutical company Fosun Pharmaceutical Group (SHA: 600196) has agreed to sell its stake in private hospital ...
Private equity giant to buy majority stake in ModMed in $5.3 billion deal
The buyer said the Boca Raton-based company's innovative technology products makes it a top provider of ambulatory health ...
Warburg Pincus Partners With Hassana to Chase Saudi Arabia Deals
Warburg Pincus LLC and Saudi Arabia’s $320 billion pension fund manager will jointly explore deals in the kingdom as the ...
Nikkei Asia22h
Fosun Pharma to sell $124m stake in hospital chain to Warburg Pincus
SHANGHAI -- Chinese drugmaker Fosun Pharmaceutical Group has agreed to sell its stake in a hospital group to U.S. private equity firm Warburg Pincus for $124.08 million.
Singapore Business Review on MSN4d
Warburg Pincus, SK D&D to invest in senior housing in South Korea
Warburg Pincus, SK D&D, and D&D Investment has formed a partnership to invest in the senior housing market in South Korea.